These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 26586342

  • 1. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems.
    Aroso IM, Silva JC, Mano F, Ferreira AS, Dionísio M, Sá-Nogueira I, Barreiros S, Reis RL, Paiva A, Duarte AR.
    Eur J Pharm Biopharm; 2016 Jan; 98():57-66. PubMed ID: 26586342
    [Abstract] [Full Text] [Related]

  • 2. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
    Duarte AR, Ferreira AS, Barreiros S, Cabrita E, Reis RL, Paiva A.
    Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620
    [Abstract] [Full Text] [Related]

  • 3. Design of controlled release systems for THEDES-Therapeutic deep eutectic solvents, using supercritical fluid technology.
    Aroso IM, Craveiro R, Rocha Â, Dionísio M, Barreiros S, Reis RL, Paiva A, Duarte AR.
    Int J Pharm; 2015 Aug 15; 492(1-2):73-9. PubMed ID: 26142248
    [Abstract] [Full Text] [Related]

  • 4. Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES).
    Kalantri S, Vora A.
    Drug Dev Ind Pharm; 2024 May 15; 50(5):387-400. PubMed ID: 38634708
    [Abstract] [Full Text] [Related]

  • 5. Selecting Excipients Forming Therapeutic Deep Eutectic Systems-A Mechanistic Approach.
    Wolbert F, Brandenbusch C, Sadowski G.
    Mol Pharm; 2019 Jul 01; 16(7):3091-3099. PubMed ID: 31095911
    [Abstract] [Full Text] [Related]

  • 6. Evaporation Behavior and Characterization of Eutectic Solvent and Ibuprofen Eutectic Solution.
    Phaechamud T, Tuntarawongsa S, Charoensuksai P.
    AAPS PharmSciTech; 2016 Oct 01; 17(5):1213-20. PubMed ID: 26669887
    [Abstract] [Full Text] [Related]

  • 7. Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment.
    Santos F, P S Leitão MI, C Duarte AR.
    Molecules; 2018 Dec 24; 24(1):. PubMed ID: 30586896
    [Abstract] [Full Text] [Related]

  • 8. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery.
    Javed S, Mangla B, Sultan MH, Almoshari Y, Sivadasan D, Alqahtani SS, Madkhali OA, Ahsan W.
    Heliyon; 2024 May 15; 10(9):e29783. PubMed ID: 38694051
    [Abstract] [Full Text] [Related]

  • 9. Formulation of Ascorbic Acid and Betaine-based Therapeutic Deep Eutectic System for Enhanced Transdermal Delivery of Ascorbic Acid.
    Song JE, Jun SH, Ryoo JY, Kang NG.
    Pharmaceutics; 2024 May 20; 16(5):. PubMed ID: 38794349
    [Abstract] [Full Text] [Related]

  • 10. Solids Turn into Liquids-Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility.
    Sarraguça MC, Ribeiro PRS, Nunes C, Seabra CL.
    Pharmaceuticals (Basel); 2022 Feb 23; 15(3):. PubMed ID: 35337077
    [Abstract] [Full Text] [Related]

  • 11. Deep eutectic solvents comprising active pharmaceutical ingredients in the development of drug delivery systems.
    Pedro SN, Freire MG, Freire CSR, Silvestre AJD.
    Expert Opin Drug Deliv; 2019 May 23; 16(5):497-506. PubMed ID: 30955386
    [Abstract] [Full Text] [Related]

  • 12. Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives.
    Li Z, Lee PI.
    Int J Pharm; 2016 May 30; 505(1-2):283-8. PubMed ID: 27079143
    [Abstract] [Full Text] [Related]

  • 13. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles.
    Morrison HG, Sun CC, Neervannan S.
    Int J Pharm; 2009 Aug 13; 378(1-2):136-9. PubMed ID: 19477257
    [Abstract] [Full Text] [Related]

  • 14. Solidification of deep eutectic solvent containing fimasartan through wet impregnation and exploration of flow attributes by modified SeDeM-SLA expert system.
    Dangre P, Avhad P, Gurumukhi V, Katolkar U, Chalikwar S.
    Eur J Pharm Biopharm; 2024 Aug 13; 201():114381. PubMed ID: 38917948
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Solubility of pharmaceutical ingredients in triglycerides.
    Brinkmann J, Huxoll F, Luebbert C, Sadowski G.
    Eur J Pharm Biopharm; 2019 Dec 13; 145():113-120. PubMed ID: 31682903
    [Abstract] [Full Text] [Related]

  • 19. Stabilizing Unstable Amorphous Menthol through Inclusion in Mesoporous Silica Hosts.
    Cordeiro T, Castiñeira C, Mendes D, Danède F, Sotomayor J, Fonseca IM, Gomes da Silva M, Paiva A, Barreiros S, Cardoso MM, Viciosa MT, Correia NT, Dionisio M.
    Mol Pharm; 2017 Sep 05; 14(9):3164-3177. PubMed ID: 28836790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.